Astrocytes in multiple sclerosis: A product of their environment

Cellular and Molecular Life Sciences

Volumn 65, Issue 17, 2008, Pages 2702-2720

  Nair, A ^a   Frederick, T J ^a   Miller, S D ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Animal models; Astrocyte; Chemokines; Cytokines; Demyelination; Multiple sclerosis; Neuroinflammation; Remyelination

Indexed keywords

CHEMOKINE; CYTOKINE; MATRIX METALLOPROTEINASE; MYELIN;

ANTIGEN PRESENTATION; ASTROCYTE; AUTOIMMUNITY; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; GLIA CELL; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOPATHOGENESIS; MULTIPLE SCLEROSIS; NERVE FIBER REGENERATION; NEUROPROTECTION; NONHUMAN; OLIGODENDROGLIA; REVIEW; STEM CELL; T LYMPHOCYTE ACTIVATION; VIRUS INFECTION;

ANIMALS; ASTROCYTES; CELL MOVEMENT; CYTOKINES; HUMANS; MULTIPLE SCLEROSIS; MYELIN SHEATH; T-LYMPHOCYTES;

ANIMALIA;

EID: 51349134916     PISSN: 1420682X     EISSN: 15691632     Source Type: Journal    
DOI: 10.1007/s00018-008-8059-5     Document Type: Review

References (216)

1. Hauser, S. L., Bhan, A. K., Gilles, F., Kemp, M., Kerr, C. and Weiner, H. L. (1986) Immunohistochemical analysis of the cellular infiltrate in multiple sclerosis lesions. Ann. Neurol. 19, 578-587.
2. McFarland, H. F. and Martin, R. (2007) Multiple sclerosis: a complicated picture of autoimmunity. Nat. Immunol. 8, 913-919.
3. Bruck, W., Kuhlmann, T. and Stadelmann, C. (2003) Remyelination in multiple sclerosis. J. Neurol. Sci. 206, 181-185.
4. Gensert, J. M. and Goldman, J. E. (1997) Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 19, 197-203.
5. Bjartmar, C. and Trapp, B. D. (2001) Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr. Opin. Neurol. 14, 271-278.
6. Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L., To, W., Kwan, S., Churakova, T., Zurawski, S., Wiekowski, M., Lira, S. A., Gorman, D., Kastelein, R. A. and Sedgwick, J. D. (2003) Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421, 744-748.
7. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schroder, R., Deckert, M., Schmidt, S., Ravid, R. and Rajewsky, K. (2000) Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 192, 393-404.
8. Bailey, S. L., Schreiner, B., McMahon, E. J. and Miller, S. D. (2007) CNS myeloid DCs presenting endogenous myelin peptides 'preferentially' polarize CD4(+) T(H)-17 cells in relapsing EAE. Nat. Immunol. 8, 172-180.
9. Ziemssen, T. and Ziemssen, F. (2005) The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE). Autoimmun. Rev. 4, 460-467.
10. He, F. and Sun, Y. E. (2007) Glial cells more than support cells? Int. J. Biochem. Cell Biol. 39, 661-665.
11. Nedergaard, M., Ransom, B. and Goldman, S. A. (2003) New roles for astrocytes: redefining the functional architecture of the brain. Trends Neurosci. 26, 523-530.
12. Chao, T. I., Rickmann, M. and Wolff, J. R. (2002) The synapse-astrocyte boundary: anatomical basis for an integrative role of glia in synaptic transmission. In Tripartate Synapses: Synaptic Transmission with Glia (Volterra, A., Magistretti, P. and Haydon, P., eds.), pp. 3-23. Oxford University Press, Oxford, New York.
13. Butt, A. M., Duncan, A. and Berry, M. (1994) Astrocyte associations with nodes of Ranvier: ultrastructural analysis of HRP-filled astrocytes in the mouse optic nerve. J. Neurocytol. 23, 486-499.
14. Eng, L. F. (1985) Glial fibrillary acidic protein (GFAP): the major protein of glial intermediate filaments in differentiated astrocytes. J. Neuroimmunol. 8, 203-214.
15. Liedtke, W., Edelmann, W., Bieri, P. L., Chiu, F. C., Cowan, N. J., Kucherlapati, R. and Raine, C. S. (1996) GFAP is necessary for the integrity of CNS white matter architecture and long-term maintenance of myelination. Neuron 17, 607-615.
16. McCall, M. A., Gregg, R. G., Behringer, R. R., Brenner, M., Delaney, C. L., Galbreath, E. J., Zhang, C. L., Pearce, R. A., Chiu, S. Y. and Messing, A. (1996) Targeted deletion in astrocyte intermediate filament (Gfap) alters neuronal physiology. Proc. Natl. Acad. Sci. U.S.A. 93, 6361-6366.
17. Nawashiro, H., Messing, A., Azzam, N. and Brenner, M. (1998) Mice lacking GFAP are hypersensitive to traumatic cerebrospinal injury. Neuroreport 9, 1691-1696.
18. Messing, A., Goldman, J. E., Johnson, A. B. and Brenner, M. (2001) Alexander disease: new insights from genetics. J. Neuropathol. Exp. Neurol. 60, 563-573.
19. Menn, B., Garcia-Verdugo, J. M., Yaschine, C., Gonzalez-Perez, O., Rowitch, D. and Alvarez-Buylla, A. (2006) Origin of oligodendrocytes in the subventricular zone of the adult brain. J. Neurosci. 26, 7907-7918.
20. Jessen, K. R. and Mirsky, R. (1984) Nonmyelin-forming Schwann cells coexpress surface proteins and intermediate filaments not found in myelin-forming cells: a study of Ran-2, A5E3 antigen and glial fibrillary acidic protein. J. Neurocytol. 13, 923-934.
21. Bertelli, E., Regoli, M., Gambelli, F., Lucattelli, M., Lungarella, G. and Bastianini, A. (2000) GFAP is expressed as a major soluble pool associated with glucagon secretory granules in A-cells of mouse pancreas. J. Histochem. Cytochem. 48, 1233-1242.
22. von Boyen, G. B., Steinkamp, M., Reinshagen, M., Schafer, K. H., Adler, G. and Kirsch, J. (2004) Proinflammatory cytokines increase glial fibrillary acidic protein expression in enteric glia. Gut 53, 222-228.
23. Korfias, S., Stranjalis, G., Papadimitriou, A., Psachoulia, C., Daskalakis, G., Antsaklis, A. and Sakas, D. E. (2006) Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr. Med. Chem. 13, 3719-3731.
24. Chaudhry, F. A., Lehre, K. P., van Lookeren Campagne, M., Ottersen, O. P., Danbolt, N. C. and Storm-Mathisen, J. (1995) Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry. Neuron 15, 711-720.
25. McKinnon, P. J. and Margolskee, R. F. (1996) SC1: a marker for astrocytes in the adult rodent brain is upregulated during reactive astrocytosis. Brain Res. 709, 27-36.
26. Brown, A. M. and Ransom, B. R. (2007) Astrocyte glycogen and brain energy metabolism. Glia 55, 1263-1271.
27. Kang, J., Jiang, L., Goldman, S. A. and Nedergaard, M. (1998) Astrocyte-mediated potentiation of inhibitory synaptic transmission. Nat. Neurosci. 1, 683-692.
28. Liberto, C. M., Albrecht, P. J., Herx, L. M., Yong, V. W. and Levison, S. W. (2004) Pro-regenerative properties of cytokine-activated astrocytes. J. Neurochem. 89, 1092-1100.
29. Martin, D. L. (1992) Synthesis and release of neuroactive substances by glial cells. Glia 5, 81-94.
30. Haydon, P. G. (2000) Neuroglial networks: neurons and glia talk to each other. Curr. Biol. 10, R712-714.
31. Dreyfus, C. F., Dai, X., Lercher, L. D., Racey, B. R., Friedman, W. J. and Black, I. B. (1999) Expression of neurotrophins in the adult spinal cord in vivo. J. Neurosci. Res. 56, 1-7.
32. Schwartz, J. P. and Nishiyama, N. (1994) Neurotrophic factor gene expression in astrocytes during development and following injury. Brain Res. Bull. 35, 403-407.
33. Nakayama, T., Momoki-Soga, T. and Inoue, N. (2003) Astrocyte-derived factors instruct differentiation of embryonic stem cells into neurons. Neurosci. Res. 46, 241-249.
34. Gard, A. L., Burrell, M. R., Pfeiffer, S. E., Rudge, J. S. and Williams, W. C. (1995) Astroglial control of oligodendrocyte survival mediated by PDGF and leukemia inhibitory factor-like protein. Development 121, 2187-2197.
35. Barres, B. A., Schmid, R., Sendnter, M. and Raff, M. C. (1993) Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 118, 283-295.
36. Sendtner, M., Kreutzberg, G. W. and Thoenen, H. (1990) Ciliary neurotrophic factor prevents the degeneration of motor neurons after axotomy. Nature 345, 440-441.
37. Chernausek, S. D. (1993) Insulin-like growth factor-I (IGF-I) production by astroglial cells: regulation and importance for epidermal growth factor-induced cell replication. J. Neurosci. Res. 34, 189-197.
38. Wolburg, H. and Lippoldt, A. (2002) Tight junctions of the blood-brain barrier: development, composition and regulation. Vascul. Pharmacol. 38, 323-337.
39. Abbott, N. J., Ronnback, L. and Hansson, E. (2006) Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 7, 41-53.
40. Schwaninger, M., Sallmann, S., Petersen, N., Schneider, A., Prinz, S., Libermann, T. A. and Spranger, M. (1999) Bradykinin induces interleukin-6 expression in astrocytes through activation of nuclear factor-kappaB. J. Neurochem. 73, 1461-1466.
41. Didier, N., Romero, I. A., Creminon, C., Wijkhuisen, A., Grassi, J. and Mabondzo, A. (2003) Secretion of interleukin-1beta by astrocytes mediates endothelin-1 and tumour necrosis factor-alpha effects on human brain microvascular endothelial cell permeability. J. Neurochem. 86, 246-254.
42. Kim, J. H., Kim, J. H., Park, J. A., Lee, S. W., Kim, W. J., Yu, Y. S. and Kim, K. W. (2006) Blood-neural barrier: intercellular communication at glio-vascular interface. J. Biochem. Mol. Biol. 39, 339-345.
43. Kleine, T. O. and Benes, L. (2006) Immune surveillance of the human central nervous system (CNS): different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons. Cytometry A 69, 147-151.
44. Ransohoff, R. M., Kivisakk, P. and Kidd, G. (2003) Three or more routes for leukocyte migration into the central nervous system. Nat. Rev. Immunol. 3, 569-581.
45. Carpentier, P. A., Begolka, W. S., Olson, J. K., Elhofy, A., Karpus, W. J. and Miller, S. D. (2005) Differential activation of astrocytes by innate and adaptive immune stimuli. Glia 49, 360-374.
46. Scumpia, P. O., Kelly, K. M., Reeves, W. H. and Stevens, B. R. (2005) Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52, 153-162.
47. Farina, C., Aloisi, F. and Meinl, E. (2007) Astrocytes are active players in cerebral innate immunity. Trends Immunol. 28, 138-145.
48. Nimmerjahn, A., Kirchhoff, F. and Helmchen, F. (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308, 1314-1318.
49. Carson, M. J., Reilly, C. R., Sutcliffe, J. G. and Lo, D. (1998) Mature microglia resemble immature antigen-presenting cells. Glia 22, 72-85.
50. Wong, G. H., Bartlett, P. F., Clark-Lewis, I., Battye, F. and Schrader, J. W. (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature 310, 688-691.
51. Nikcevich, K. M., Gordon, K. B., Tan, L., Hurst, S. D., Kroepfl, J. F., Gardinier, M., Barrett, T. A. and Miller, S. D. (1997) Interferon-gamma activated primary murine astrocytes express B7 costimulatory molecules and prime naive antigen-specific T cells. J. Immunol. 158, 614-621.
52. Sedgwick, J. D., Mossner, R., Schwender, S. and ter Meulen, V. (1991) Major histocompatibility complex-expressing non-hematopoietic astroglial cells prime only CD8 + T lymphocytes: astroglial cells as perpetuators but not initiators of CD4 + T cell responses in the central nervous system. J. Exp. Med. 173, 1235-1246.
53. Tan, L. J., Gordon, K. B., Mueller, J. P., Matis, L. A. and Miller, S. D. (1998) Presentation of proteolipid protein epitopes and B7-1-dependent activation of encephalitogenic T cells by IFN-gamma-activated SJL/Jastrocytes. J. Immunol. 160, 4271-4279.
54. Vass, K. and Lassmann, H. (1990) Intrathecal application of interferon gamma. Progressive appearance of MHC antigens within the rat nervous system. Am. J. Pathol. 137, 789-800.
55. Barcia, C., Thomas, C. E., Curtin, J. F., King, G. D., Wawrowsky, K., Candolfi, M., Xiong, W. D., Liu, C., Kroeger, K., Boyer, O., Kupiec-Weglinski, J., Klatzmann, D., Castro, M. G. and Lowenstein, P. R. (2006) In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain. J. Exp. Med. 203, 2095-2107.
56. Dong, Y. and Benveniste, E. N. (2001) Immune function of astrocytes. Glia 36, 180-190.
57. Gimenez, M. A., Sim, J. E. and Russell, J. H. (2004) TNFR1-dependent VCAM-1 expression by astrocytes exposes the CNS to destructive inflammation. J. Neuroimmunol. 151, 116-125.
58. Wong, G. H. W., Bartlett, P. F., Clark-Lewis, I., Battye, F. and Schrader, J. W. (1984) Inducible expression of H-2 and Ia antigens on brain cells. Nature 310, 688-691.
59. Hoftberger, R., Aboul-Enein, F., Brueck, W., Lucchinetti, C., Rodriguez, M., Schmidbauer, M., Jellinger, K. and Lassmann, H. (2004) Expression of major histocompatibility complex class I molecules on the different cell types in multiple sclerosis lesions. Brain Pathol. 14, 43-50.
60. Traugott, U., McFarlin, D. E. and Raine, C. S. (1986) Immunopathology of the lesion in chronic relapsing experimental autoimmune encephalomyelitis in the mouse. Cell. Immunol. 99, 395-410.
61. Zeinstra, E., Wilczak, N. and De Keyser, J. (2003) Reactive astrocytes in chronic active lesions of multiple sclerosis express co-stimulatory molecules B7-1 and B7-2. J. Neuroimmunol. 135, 166-171.
62. Zeinstra, E., Wilczak, N., Streefland, C. and De Keyser, J. (2000) Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 11, 89-91.
63. Bo, L., Mork, S., Kong, P. A., Nyland, H., Pardo, C. A. and Trapp, B. D. (1994) Detection of MHC class II-antigens on macrophages and microglia, but not on astrocytes and endothelia in active multiple sclerosis lesions. J. Neuroimmunol. 51, 135-146.
64. Hayashi, T., Burks, J. S. and Hauser, S. L. (1988) Expression and cellular localization of major histocompatibility complex antigens in active multiple sclerosis lesions. Ann. N.Y. Acad. Sci. 540, 301-305.
65. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M. N., Cuzner, M. L. and Hafler, D. A. (1995) Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD80), and interleukin 12 cytokine in multiple sclerosis lesions. J. Exp. Med. 182, 1985-1996.
66. Cross, A. H. and Ku, G. (2000) Astrocytes and central nervous system endothelial cells do not express B7-1 (CD80) or B7-2 (CD86) immunoreactivity during experimental autoimmune encephalomyelitis. J. Neuroimmunol. 110, 76-82.
67. Butter, C., O'Neill, J. K., Baker, D., Gschmeissner, S. E. and Turk, J. L. (1991) An immunoelectron microscopical study of the expression of class II major histocompatibility complex during chronic relapsing experimental allergic encephalomyelitis in Biozzi AB/H mice. J. Neuroimmunol. 33, 37-42.
68. Issazadeh, S., Navikas, V., Schaub, M., Sayegh, M. and Khoury, S. (1998) Kinetics of expression of costimulatory molecules and their ligands in murine relapsing experimental autoimmune encephalomyelitis in vivo. J. Immunol. 161, 1104-1112.
69. Tan, L. J., Vanderlugt, C. L., McRae, B. L. and Miller, S. D. (1998) Regulation of the effector stages of experimental autoimmune encephalomyelitis via neuroantigen-specific tolerance induction. III. A role for clonal anergy/deletion. Autoimmunity 27, 13-28.
70. Kort, J. J., Kawamura, K., Fugger, L., Weissert, R. and Forsthuber, T. G. (2006) Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice. J. Neuroimmunol. 173, 23-34.
71. Stuve, O., Youssef, S., Slavin, A. J., King, C. L., Patarroyo, J. C., Hirschberg, D. L., Brickey, W. J., Soos, J. M., Piskurich, J. F., Chapman, H. A. and Zamvil, S. S. (2002) The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease. J. Immunol. 169, 6720-6732.
72. Fontana, A., Fierz, W. and Wekerle, H. (1984) Astrocytes present myelin basic protein to encephalitogenic T-cell lines. Nature 307, 273-276.
73. Xiao, B. G., Diab, A., Zhu, J., van der Meide, P. and Link, H. (1998) Astrocytes induce hyporesponses of myelin basic protein-reactive T and B cell function. J. Neuroimmunol. 89, 113-121.
74. Sobel, R. A., Mitchell, M. E. and Fondren, G. (1990) Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am. J. Pathol. 136, 1309-1316.
75. Rosenman, S. J., Shrikant, P., Dubb, L., Benveniste, E. N. and Ransohoff, R. M. (1995) Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines. J. Immunol. 154, 1888-1899.
76. Cannella, B. and Raine, C. S. (1995) The adhesion molecule and cytokine profile of multiple sclerosis lesions. Ann. Neurol. 37, 424-435.
77. Hemmer, B., Archelos, J. J. and Hartung, H. P. (2002) New concepts in the immunopathogenesis of multiple sclerosis. Nat. Rev. Neurosci. 3, 291-301.
78. Tompkins, S. M., Padilla, J., Dal Canto, M. C., Ting, J. P., Van Kaer, L. and Miller, S. D. (2002) De novo central nervous system processing of myelin antigen is required for the initiation of experimental autoimmune encephalomyelitis. J. Immunol. 168, 4173-4183.
79. Harrington, L. E., Mangan, P. R. and Weaver, C. T. (2006) Expanding the effector CD4 T-cell repertoire: the Th17 lineage. Curr. Opin. Immunol. 18, 349-356.
80. Tzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M. and Fugger, L. (2007) Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associatedwith active disease in multiple sclerosis. Am. J. Pathol.
81. Constantinescu, C. S., Tani, M., Ransohoff, R. M., Wysocka, M., Hilliard, B., Fujioka, T., Murphy, S., Tighe, P. J., Sarma, J. D., Trinchieri, G. and Rostami, A. (2005) Astrocytes as antigen-presenting cells: expression of IL-12/IL-23. J. Neurochem. 95, 331-340.
82. O'Garra, A. and Arai, N. (2000) The molecular basis of T helper 1 and T helper 2 cell differentiation. Trends Cell Biol. 10, 542-550.
83. Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., Kastelein, R. A. and Cua, D. J. (2005) IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 201, 233-240.
84. Miljkovic, D., Momcilovic, M., Stojanovic, I., Stosic-Grujicic, S., Ramic, Z. and Mostarica-Stojkovic, M. (2007) Astrocytes stimulate interleukin-17 and interferon-gamma production in vitro. J. Neurosci. Res. 85, 3598-3606.
85. Becher, B., Durell, B. G. and Noelle, R. J. (2003) IL-23 produced by CNS-resident cells controls T cell encephalitogenicity during the effector phase of experimental autoimmune encephalomyelitis. J. Clin. Invest. 112, 1186-1191.
86. Bettelli, E., Oukka, M. and Kuchroo, V. K. (2007) T(H)-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345-350.
87. Sorensen, T. L., Tani, M., Jensen, J., Pierce, V., Lucchinetti, C., Folcik, V. A., Qin, S., Rottman, J., Sellebjerg, F., Strieter, R. M., Frederiksen, J. L. and Ransohoff, R. M. (1999) Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J. Clin. Invest. 103, 807-815.
88. Simpson, J. E., Newcombe, J., Cuzner, M. L. and Woodroofe, M. N. (2000) Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 26, 133-142.
89. Balashov, K. E., Rottman, J. B., Weiner, H. L. and Hancock, W. W. (1999) CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions. Proc. Natl. Acad. Sci. U.S.A. 96, 6873-6878.
90. Calderon, T. M., Eugenin, E. A., Lopez, L., Kumar, S. S., Hesselgesser, J., Raine, C. S. and Berman, J. W. (2006) A role for CXCL12 (SDF-1alpha) in the pathogenesis of multiple sclerosis: regulation of CXCL12 expression in astrocytes by soluble myelin basic protein. J. Neuroimmunol. 177, 27-39.
91. Tanuma, N., Sakuma, H., Sasaki, A. and Matsumoto, Y. (2006) Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol.(Berl) 112, 195-204.
92. Van Der Voorn, P., Tekstra, J., Beelen, R. H., Tensen, C. P., Van Der Valk, P. and De Groot, C. J. (1999) Expression of MCP-1 by reactive astrocytes in demyelinating multiple sclerosis lesions. Am. J. Pathol. 154, 45-51.
93. Salmaggi, A., Gelati, M., Dufour, A., Corsini, E., Pagano, S., Baccalini, R., Ferrero, E., Scabini, S., Silei, V., Ciusani, E. and De Rossi, M. (2002) Expression and modulation of IFN-gamma-inducible chemokines (IP-10, Mig, and I-TAC) in human brain endothelium and astrocytes: possible relevance for the immune invasion of the central nervous system and the pathogenesis of multiple sclerosis. J. Interferon Cytokine Res. 22, 631-640.
94. Barna, B. P., Pettay, J., Barnett, G. H., Zhou, P., Iwasaki, K. and Estes, M. L. (1994) Regulation of monocyte chemoattractant protein-1 expression in adult human non-neoplastic astrocytes is sensitive to tumor necrosis factor (TNF) or antibody to the 55-kDa TNF receptor. J. Neuroimmunol. 50, 101-107.
95. Karpus, W. J. and Ransohoff, R. M. (1998) Chemokine regulation of experimental autoimmune encephalomyelitis: temporal and spatial expression patterns govern disease pathogenesis. J. Immunol. 161, 2667-2671.
96. Ransohoff, R. M., Hamilton, T. A., Tani, M., Stoler, M. H., Shick, H. E., Major, J. A., Estes, M. L., Thomas, D. M. and Tuohy, V. K. (1993) Astrocyte expression of mRNA encoding cytokines IP-10 and JE/MCP- 1 in experimental autoimmune encephalomyelitis. FASEB J. 7, 592-600.
97. Carter, S. L., Muller, M., Manders, P. M. and Campbell, I. L. (2007) Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia 55, 1728-1739.
98. Glabinski, A. R., Tani, M., Strieter, R. M., Tuohy, V. K. and Ransohoff, R. M. (1997) Synchronous synthesis of alpha- and beta-chemokines by cells of diverse lineage in the central nervous system of mice with relapses of chronic experimental autoimmune encephalomyelitis. Am. J. Pathol. 150, 617-630.
99. Sunnemark, D., Eltayeb, S., Nilsson, M., Wallstrom, E., Lassmann, H., Olsson, T., Berg, A. L. and Ericsson-Dahlstrand, A. (2005) CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J. Neuroinflam. 2, 17.
100. Cook, D. N., Chen, S. C., Sullivan, L. M., Manfra, D. J., Wiekowski, M. T., Prosser, D. M., Vassileva, G. and Lira, S. A. (2001) Generation and analysis of mice lacking the chemokine fractalkine. Mol. Cell Biol. 21, 3159-3165.
101. Hurwitz, A. A., Lyman, W. D. and Berman, J. W. (1995) Tumor necrosis factor alpha and transforming growth factor beta upregulate astrocyte expression of monocyte chemoattractant protein-1. J. Neuroimmunol. 57, 193-198.
102. Hayashi, M., Luo, Y., Laning, J., Strieter, R. M. and Dorf, M. E. (1995) Production and function of monocyte chemoattractant protein-1 and other beta-chemokines in murine glial cells. J. Neuroimmunol. 60, 143-150.
103. Croxford, J. L., Olson, J. K. and Miller, S. D. (2002) Epitope spreading and molecular mimicry as triggers of autoimmunity in the Theiler's virus induced demyelinating disease model of multiple sclerosis Autoimmun. Rev. 1 251-260.
104. Miller, S. D., Vanderlugt, C. L., Begolka, W. S., Pao, W., Yauch, R. L., Neville, K. L., Katz-Levy, Y., Carrizosa, A. and Kim, B. S. (1997) Persistent infection with Theiler's virus leads to CNS autoimmunity via epitope spreading. Nat. Med. 3, 1133-1136.
105. Hoffman, L. M., Fife, B. T., Begolka, W. S., Miller, S. D. and Karpus, W. J. (1999) Central nervous system chemokine expression during Theiler's virus-induced demyelinating disease. J. Neurovirol. 5, 635-642.
106. Murray, P. D., Krivacic, K., Chernosky, A., Wei, T., Ransohoff, R. M. and Rodriguez, M. (2000) Biphasic and regionally-restricted chemokine expression in the central nervous system in the Theiler's virus model of multiple sclerosis. J. Neurovirol. 6 Suppl 1, S44-52.
107. Carpentier, P. A., Williams, B. R. and Miller, S. D. (2007) Distinct roles of protein kinase R and toll-like receptor 3 in the activation of astrocytes by viral stimuli. Glia 55, 239-252.
108. Palma, J. P. and Kim, B. S. (2001) Induction of selected chemokines in glial cells infected with Theiler's virus. J. Neuroimmunol. 117, 166-170.
109. Kwon, D., Fuller, A. C., Palma, J. P., Choi, I. H. and Kim, B. S. (2004) Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP-1 and NF-kappa, B. Glia 45, 287-296.
110. Rubio, N., Sanz-Rodriguez, F. and Lipton, H. L. (2006) Theiler's virus induces the MIP-2 chemokine (CXCL2) in astrocytes from genetically susceptible but not from resistant mouse strains. Cell. Immunol. 239, 31-40.
111. Carpentier, P. A., Duncan, D. S. and Miller, S. D. (2008) Glial toll-like receptor signaling in central nervous system infection and autoimmunity. Brain. Behav. Immun. 22, 140-147.
112. Mattson, M. P. and Taub, D. D. (2004) Ancient viral protein enrages astrocytes in multiple sclerosis. Nat. Neurosci. 7, 1021-1023.
113. Antony, J. M., van Marle, G., Opii, W., Butterfield, D. A., Mallet, F., Yong, V. W., Wallace, J. L., Deacon, R. M., Warren, K. and Power, C. (2004) Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Nat. Neurosci. 7, 1088-1095.
114. Antony, J. M., Ellestad, K. K., Hammond, R., Imaizumi, K., Mallet, F., Warren, K. G. and Power, C. (2007) The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes. J. Immunol. 179, 1210-1224.
115. Aloisi, F., Ria, F., Penna, G. and Adorini, L. (1998) Microglia are more efficient than astrocytes in antigen processing and in Th1 but not Th2 activation. J. Immunol. 160, 4671-4680.
116. Aloisi, F., Penna, G., Cerase, J., Menendez, I. B. and Adorini, L. (1997) IL-12 production by central nervous system microglia is inhibited by astrocytes. J. Immunol. 159, 1604-1612.
117. Aloisi, F., Ria, F. and Adorini, L. (2000) Regulation of T-cell responses by CNS antigen-presenting cells: different roles for microglia and astrocytes. Immunol. Today 21, 141-147.
118. Abbas, A. K., Murphy, K. M. and Sher, A. (1996) Functional diversity of helper T lymphocytes. Nature 383, 787-793.
119. Mosmann, T. R. and Sad, S. (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 17, 138-146.
120. Bsibsi, M., Persoon-Deen, C., Verwer, R. W., Meeuwsen, S., Ravid, R. and Van Noort, J. M. (2006) Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53, 688-695.
121. Bsibsi, M., Ravid, R., Gveric, D. and van Noort, J. M. (2002) Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61, 1013-1021.
122. Meinl, E., Aloisi, F., Ertl, B., Weber, F., DeWaal Malefyt, R., Wekerle, H. and Hohlfeld, R. (1994) Multiple sclerosis. Immunomodulatory effects of human astrocytes on T cells. Brain 117, 1323-1332.
123. Weber, F., Meinl, E., Aloisi, F., Nevinny-Stickel, C., Albert, E., Wekerle, H. and Hohlfeld, R. (1994) Human astrocytes are only partially competent antigen presenting cells. Possible implications for lesion development in multiple sclerosis. Brain 117, 59-69.
124. Gimsa, U., Oren, A., Pandiyan, P., Teichmann, D., Bechmann, I., Nitsch, R. and Brunner-Weinzierl, M. C. (2004) Astrocytes protect the CNS: antigen-specific T helper cell responses are inhibited by astrocyte-induced upregulation of CTLA-4 (CD152). J. Mol. Med. 82, 364-372.
125. Chambers, C. A., Krummel, M. F., Boitel, B., Hurwitz, A., Sullivan, T. J., Fournier, S., Cassell, D., Brunner, M. and Allison, J. P. (1996) The role of CTLA-4 in the regulation and initiation of T cell responses. Immunol. Rev. 153, 27-46.
126. Trajkovic, V., Vuckovic, O., Stosic-Grujicic, S., Miljkovic, D., Popadic, D., Markovic, M., Bumbasirevic, V., Backovic, A., Cvetkovic, I., Harhaji, L., Ramic, Z. and Mostarica, S. M. (2004) Astrocyte-induced regulatory T cells mitigate CNS autoimmunity. Glia 47, 168-179.
127. Fitzgerald, D. C., Ciric, B., Touil, T., Harle, H., Grammatikopolou, J., Das Sarma, J., Gran, B., Zhang, G. X. and Rostami, A. (2007) Suppressive effect of IL-27 on encephalitogenic Th17 cells and the effector phase of experimental autoimmune encephalomyelitis. J. Immunol. 179, 3268-3275.
128. Eng, L. F., Reier, P. J. and Houle, J. D. (1987) Astrocyte activation and fibrous gliosis: glial fibrillary acidic protein immunostaining of astrocytes following intraspinal cord grafting of fetal CNS tissue. Prog. Brain Res. 71, 439-455.
129. Reier, P. J. and Houle, J. D. (1988)The glial scar: its bearing on axonal elongation and transplantation approaches to CNS repair. Adv. Neurol. 47, 87-138.
130. Norton, W. T., Aquino, D. A., Hozumi, I., Chiu, F. C. and Brosnan, C. F. (1992) Quantitative aspects of reactive gliosis: a review. Neurochem. Res. 17, 877-885.
131. Holley, J. E., Gveric, D., Newcombe, J., Cuzner, M. L. and Gutowski, N. J. (2003) Astrocyte characterization in the multiple sclerosis glial scar. Neuropathol. Appl. Neurobiol. 29, 434-444.
132. Smith, M. E. and Eng, L. F. (1987) Glial fibrillary acidic protein in chronic relapsing experimental allergic encephalomyelitis in SJL/J mice. J. Neurosci. Res. 18, 203-208.
133. Fok-Seang, J., Smith-Thomas, L. C., Meiners, S., Muir, E., Du, J. S., Housden, E., Johnson, A. R., Faissner, A., Geller, H. M. and Keynes, R. J. (1995) An analysis of astrocytic cell lines with different abilities to promote axon growth. Brain Res. 689, 207-223.
134. Wilby, M. J., Muir, E. M., Fok-Seang, J., Gour, B. J., Blaschuk, O. W. and Fawcett, J. W. (1999) N-Cadherin inhibits Schwann cell migration on astrocytes. Mol. Cell. Neurosci. 14, 66-84.
135. Franklin, R. J., Gilson, J. M. and Blakemore, W. F. (1997) Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J. Neurosci. Res. 50, 337-344.
136. Baron-Van Evercooren, A., Avellana-Adalid, V., Ben Younes-Chennoufi, A., Gansmuller, A., Nait-Oumesmar, B. and Vignais, L. (1996) Cell-cell interactions during the migration of myelin-forming cells transplanted in the demyelinated spinal cord. Glia 16, 147-164.
137. Blakemore, W. F. and Crang, A. J. (1989) The relationship between type-1 astrocytes, Schwann cells and oligodendrocytes following transplantation of glial cell cultures into demyelinating lesions in the adult rat spinal cord. J. Neurocytol. 18, 519-528.
138. Bannerman, P., Hahn, A., Soulika, A., Gallo, V. and Pleasure, D. (2007) Astrogliosis in EAE spinal cord: derivation from radial glia, and relationships to oligodendroglia. Glia 55, 57-64.
139. Messersmith, D. J., Murtie, J. C., Le, T. Q., Frost, E. E. and Armstrong, R. C. (2000) Fibroblast growth factor 2 (FGF2) and FGF receptor expression in an experimental demyelinating disease with extensive remyelination. J. Neurosci. Res. 62, 241-256.
140. Goddard, D. R., Berry, M. and Butt, A. M. (1999) In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. J. Neurosci. Res. 57, 74-85.
141. Sherman, L. S., Struve, J. N., Rangwala, R., Wallingford, N. M., Tuohy, T. M. and Kuntz, C. T. (2002) Hyaluronate-based extracellularmatrix: keeping glia in their place. Glia 38, 93-102.
142. Quackenbush, E. J., Cruz, T. F., Moscarello, M. A. and Letarte, M. (1985) Identification of three antigens in human brain associated with similar antigens on human leukaemic cells. Biochem. J. 225, 291-299.
143. Williams, A., Piaton, G. and Lubetzki, C. (2007) Astrocytes - friends or foes in multiple sclerosis? Glia 55, 1300-1312.
144. Soilu-Hanninen, M., Laaksonen, M. and Hanninen, A. (2005) Hyaluronate receptor (CD44) and integrin alpha4 (CD49d) are up-regulated on T cells during MS relapses. J. Neuroimmunol. 166, 189-192.
145. Back, S. A., Tuohy, T. M., Chen, H., Wallingford, N., Craig, A., Struve, J., Luo, N. L., Banine, F., Liu, Y., Chang, A., Trapp, B. D., Bebo, B. F., Jr., Rao, M. S. and Sherman, L. S. (2005) Hyaluronan accumulates in demyelinated lesions and inhibits oligodendrocyte progenitor maturation. Nat. Med. 11, 966-972.
146. Silver, J. and Miller, J. H. (2004) Regeneration beyond the glial scar. Nat. Rev. Neurosci. 5, 146-156.
147. Kobayashi, N. R., Fan, D. P., Giehl, K. M., Bedard, A. M., Wiegand, S. J. and Tetzlaff, W. (1997) BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons after cervical axotomy, stimulate GAP-43 and Talpha1-tubulin mRNA expression, and promote axonal regeneration. J. Neurosci. 17, 9583-9595.
148. Fawcett, J. W., Housden, E., Smith-Thomas, L. and Meyer, R. L. (1989) The growth of axons in three-dimensional astrocyte cultures. Dev. Biol. 135, 449-458.
149. McKeon, R. J., Hoke, A. and Silver, J. (1995) Injury-induced proteoglycans inhibit the potential for laminin-mediated axon growth on astrocytic scars. Exp. Neurol. 136, 32-43.
150. McKeon, R. J., Jurynec, M. J. and Buck, C. R. (1999) The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar. J. Neurosci. 19, 10778-10788.
151. Sobel, R. A. (2001) The extracellular matrix in multiple sclerosis: an update. Braz. J. Med. Biol. Res. 34, 603-609.
152. Asher, R. A., Morgenstern, D. A., Fidler, P. S., Adcock, K. H., Oohira, A., Braistead, J. E., Levine, J. M., Margolis, R. U., Rogers, J. H. and Fawcett, J. W. (2000) Neurocan is upregulated in injured brain and in cytokine-treated astrocytes. J. Neurosci. 20, 2427-2438.
153. Yamada, H., Fredette, B., Shitara, K., Hagihara, K., Miura, R., Ranscht, B., Stallcup, W. B. and Yamaguchi, Y. (1997) The brain chondroitin sulfate proteoglycan brevican associates with astrocytes ensheathing cerebellar glomeruli and inhibits neurite outgrowth from granule neurons. J. Neurosci. 17, 7784-7795.
154. Quaglia, X., Beggah, A. T., Seidenbecher, C. and Zurn, A. D. (2008) Delayed priming promotes CNS regeneration postrhizotomy in Neurocan and Brevican-deficient mice. Brain 131, 240-249.
155. Stallcup, W. B. and Beasley, L. (1987) Bipotential glial precursor cells of the optic nerve express the NG2 proteoglycan. J. Neurosci. 7, 2737-2744.
156. Zhu, X., Bergles, D. E. and Nishiyama, A. (2008) NG2 cells generate both oligodendrocytes and gray matter astrocytes. Development 135, 145-157.
157. Trotter, J. (2005) NG2-positive cells in CNS function and the pathological role of antibodies against NG2 in demyelinating diseases. J. Neurol. Sci. 233, 37-42.
158. Fidler, P. S., Schuette, K., Asher, R. A., Dobbertin, A., Thornton, S. R., Calle-Patino, Y., Muir, E., Levine, J. M., Geller, H. M., Rogers, J. H., Faissner, A. and Fawcett, J. W. (1999) Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J. Neurosci. 19, 8778-8788.
159. Chen, Z. J., Ughrin, Y. and Levine, J. M. (2002) Inhibition of axon growth by oligodendrocyte precursor cells. Mol. Cell. Neurosci. 20, 125-139.
160. Sobel, R. A. (2005) Ephrin A receptors and ligands in lesions and normal-appearing white matter in multiple sclerosis. Brain Pathol. 15, 35-45.
161. Bundesen, L. Q., Scheel, T. A., Bregman, B. S. and Kromer, L. F. (2003) Ephrin-B2 and EphB2 regulation of astrocytemeningeal fibroblast interactions in response to spinal cord lesions in adult rats. J. Neurosci. 23, 7789-7800.
162. Wahl, S., Barth, H., Ciossek, T., Aktories, K. and Mueller, B. K. (2000) Ephrin-A5 induces collapse of growth cones by activating Rho and Rho kinase. J. Cell Biol. 149, 263-270.
163. Satoh, J., Onoue, H., Arima, K. and Yamamura, T. (2005) Nogo-A and nogo receptor expression in demyelinating lesions of multiple sclerosis. J. Neuropathol. Exp. Neurol. 64, 129-138.
164. Karnezis, T., Mandemakers, W., McQualter, J. L., Zheng, B., Ho, P. P., Jordan, K. A., Murray, B. M., Barres, B., Tessier-Lavigne, M. and Bernard, C. C. (2004) The neurite outgrowth inhibitor Nogo A is involved in autoimmune-mediated demyelination. Nat. Neurosci. 7, 736-744.
165. Satoh, J., Tabunoki, H., Yamamura, T., Arima, K. and Konno, H. (2007) TROY and LINGO-1 expression in astrocytes and macrophages/microglia in multiple sclerosis lesions. Neuropathol. Appl. Neurobiol. 33, 99-107.
166. Bush, T. G., Puvanachandra, N., Horner, C. H., Polito, A., Ostenfeld, T., Svendsen, C. N., Mucke, L., Johnson, M. H. and Sofroniew, M. V. (1999) Leukocyte infiltration, neuronal degeneration, and neurite outgrowth after ablation of scarforming, reactive astrocytes in adult transgenic mice. Neuron 23, 297-308.
167. Gardner, J. and Ghorpade, A. (2003) Tissue inhibitor of metalloproteinase (TIMP)-1: the TIMPed balance of matrix metalloproteinases in the central nervous system. J. Neurosci. Res. 74, 801-806.
168. Uhm, J. H., Dooley, N. P., Oh, L. Y. and Yong, V. W. (1998) Oligodendrocytes utilize amatrix metalloproteinase, MMP-9, to extend processes along an astrocyte extracellular matrix. Glia 22, 53-63.
169. Larsen, P. H., Wells, J. E., Stallcup, W. B., Opdenakker, G. and Yong, V. W. (2003) Matrix metalloproteinase-9 facilitates remyelination in part by processing the inhibitory NG2 proteoglycan. J. Neurosci. 23, 11127-11135.
170. Pagenstecher, A., Stalder, A. K., Kincaid, C. L., Shapiro, S. D. and Campbell, I. L. (1998) Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states. Am. J. Pathol. 152, 729-741.
171. Crocker, S. J., Whitmire, J. K., Frausto, R. F., Chertboonmuang, P., Soloway, P. D., Whitton, J. L. and Campbell, I. L. (2006) Persistent macrophage/microglial activation and myelin disruption after experimental autoimmune encephalomyelitis in tissue inhibitor of metalloproteinase-1- deficient mice. Am. J. Pathol. 169, 2104-2116.
172. Belmadani, A., Tran, P. B., Ren, D. and Miller, R. J. (2006) Chemokines regulate the migration of neural progenitors to sites of neuroinflammation. J. Neurosci. 26, 3182-3191.
173. Yan, Y. P., Sailor, K. A., Lang, B. T., Park, S. W., Vemuganti, R. and Dempsey, R. J. (2007) Monocyte chemoattractant protein-1 plays a critical role in neuroblast migration after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 27, 1213-1224.
174. Liu, X. S., Zhang, Z. G., Zhang, R. L., Gregg, S. R., Wang, L., Yier, T. and Chopp, M. (2007) Chemokine ligand 2 (CCL2) induces migration and differentiation of subventricular zone cells after stroke. J. Neurosci. Res. 85, 2120-2125.
175. Xu, Q., Wang, S., Jiang, X., Zhao, Y., Gao, M., Zhang, Y., Wang, X., Tano, K., Kanehara, M., Zhang, W. and Ishida, T. (2007) Hypoxia-induced astrocytes promote the migration of neural progenitor cells via vascular endothelial factor, stem cell factor, stromal-derived factor-1alpha and monocyte chemoattractant protein-1 upregulation in vitro. Clin. Exp. Pharmacol. Physiol. 34, 624-631.
176. Maysami, S., Nguyen, D., Zobel, F., Pitz, C., Heine, S., Hopfner, M. and Stangel, M. (2006) Modulation of rat oligodendrocyte precursor cells by the chemokine CXCL12. Neuroreport 17, 1187-1190.
177. Padovani-Claudio, D. A., Liu, L., Ransohoff, R. M. and Miller, R. H. (2006) Alterations in the oligodendrocyte lineage, myelin, and white matter in adult mice lacking the chemokine receptor CXCR2. Glia 54, 471-483.
178. Filipovic, R. and Zecevic, N. (2008) The effect of CXCL1 on human fetal oligodendrocyte progenitor cells. Glia 56, 1-15.
179. Rodriguez, M., Pavelko, K. D., McKinney, C. W. and Leibowitz, J. L. (1994) Recombinant human IL-6 suppresses demyelination in a viral model of multiple sclerosis. J. Immunol. 153, 3811-3821.
180. Willenborg, D. O., Fordham, S. A., Cowden, W. B. and Ramshaw, I. A. (1995) Cytokines and murine autoimmune encephalomyelitis: inhibition or enhancement of disease with antibodies to select cytokines, or by delivery of exogenous cytokines using a recombinant vaccinia virus system. Scand. J. Immunol. 41, 31-41.
181. Eugster, H. P., Frei, K., Kopf, M., Lassmann, H. and Fontana, A. (1998) IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur. J. Immunol. 28, 2178-2187.
182. Schonrock, L. M., Gawlowski, G. and Bruck, W. (2000) Interleukin-6 expression in human multiple sclerosis lesions. Neurosci. Lett. 294, 45-48.
183. Valerio, A., Ferrario, M., Dreano, M., Garotta, G., Spano, P. and Pizzi, M. (2002) Soluble interleukin-6 (IL-6) receptor/IL-6 fusion protein enhances in vitro differentiation of purified rat oligodendroglial lineage cells. Mol. Cell Neurosci. 21, 602-615.
184. Marz, P., Heese, K., Dimitriades-Schmutz, B., Rose-John, S. and Otten, U. (1999) Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia 26, 191-200.
185. Biber, K., Pinto-Duarte, A., Wittendorp, M. C., Dolga, A. M., Fernandes, C. C., Von Frijtag Drabbe Kunzel, J., Keijser, J. N., de Vries, R., Ijzerman, A. P., Ribeiro, J. A., Eisel, U., Sebastiao, A. M. and Boddeke, H. W. (2007) Interleukin-6 Upregulates Neuronal Adenosine A(1) Receptors: Implications for Neuromodulation and Neuroprotection. Neuropsychopharmacol. Epub ahead of print
186. Zhang, Y., Taveggia, C., Melendez-Vasquez, C., Einheber, S., Raine, C. S., Salzer, J. L., Brosnan, C. F. and John, G. R. (2006) Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J. Neurosci. 26, 12174-12185.
187. Logan, A., Berry, M., Gonzalez, A. M., Frautschy, S. A., Sporn, M. B. and Baird, A. (1994) Effects of transforming growth factor beta 1 on scar production in the injured central nervous system of the rat. Eur. J. Neurosci. 6, 355-363.
188. Herx, L. M. and Yong, V. W. (2001) Interleukin-1 beta is required for the early evolution of reactive astrogliosis following CNS lesion. J. Neuropathol. Exp. Neurol. 60, 961-971.
189. Stankoff, B., Aigrot, M. S., Noel, F., Wattilliaux, A., Zalc, B. and Lubetzki, C. (2002) Ciliary neurotrophic factor (CNTF) enhances myelin formation: a novel role for CNTF and CNTF-related molecules. J. Neurosci. 22, 9221-9227.
190. Park, S. K., Solomon, D. and Vartanian, T. (2001) Growth factor control of CNS myelination. Dev. Neurosci. 23, 327-337.
191. Ishibashi, T., Dakin, K. A., Stevens, B., Lee, P. R., Kozlov, S. V., Stewart, C. L. and Fields, R. D. (2006) Astrocytes promote myelination in response to electrical impulses. Neuron 49, 823-832.
192. Herx, L. M., Rivest, S. and Yong, V. W. (2000) Central nervous system-initiated inflammation and neurotrophism in trauma: IL-1 beta is required for the production of ciliary neurotrophic factor. J. Immunol. 165, 2232-2239.
193. Mason, J. L., Suzuki, K., Chaplin, D. D. and Matsushima, G. K. (2001) Interleukin-1beta promotes repair of the CNS. J. Neurosci. 21, 7046-7052.
194. Stockli, K. A., Lillien, L. E., Naher-Noe, M., Breitfeld, G., Hughes, R. A., Raff, M. C., Thoenen, H. and Sendtner, M. (1991) Regional distribution, developmental changes, and cellular localization of CNTF-mRNA and protein in the rat brain. J. Cell Biol. 115, 447-459.
195. McMorris, F. A., Mozell, R. L., Carson, M. J., Shinar, Y., Meyer, R. D. and Marchetti, N. (1993) Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann. N. Y. Acad. Sci. 692, 321-334.
196. Chesik, D., Wilczak, N. and De Keyser, J. (2007) The insulin-like growth factor system in multiple sclerosis. Int. Rev. Neurobiol. 79, 203-226.
197. Albrecht, P. J., Murtie, J. C., Ness, J. K., Redwine, J. M., Enterline, J. R., Armstrong, R. C. and Levison, S. W. (2003) Astrocytes produce CNTF during the remyelination phase of viral-induced spinal cord demyelination to stimulate FGF-2 production. Neurobiol. Dis. 13, 89-101.
198. Richardson, P. M. (1994) Ciliary neurotrophic factor: a review. Pharmacol. Ther. 63, 187-198.
199. Mayer, M., Bhakoo, K. and Noble, M. (1994) Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120, 143-153.
200. Talbott, J. F., Cao, Q., Bertram, J., Nkansah, M., Benton, R. L., Lavik, E. and Whittemore, S. R. (2007) CNTF promotes the survival and differentiation of adult spinal cord-derived oligodendrocyte precursor cells in vitro but fails to promote remyelination in vivo. Exp. Neurol. 204, 485-489.
201. Sendtner, M., Carroll, P., Holtmann, B., Hughes, R. A. and Thoenen, H. (1994) Ciliary neurotrophic factor. J. Neurobiol. 25, 1436-1453.
202. Albrecht, P. J., Dahl, J. P., Stoltzfus, O. K., Levenson, R. and Levison, S. W. (2002) Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of fibroblast growth factor-2, to increase motor neuron survival. Exp. Neurol. 173, 46-62.
203. Albrecht, P. J., Enterline, J. C., Cromer, J. and Levison, S. W. (2007) CNTF-activated astrocytes release a soluble trophic activity for oligodendrocyte progenitors. Neurochem. Res. 32, 263-271.
204. Malik, O., Compston, D. A. and Scolding, N. J. (1998) Interferon-beta inhibits mitogen induced astrocyte proliferation in vitro. J. Neuroimmunol. 86, 155-162.
205. Stewart, V. C., Giovannoni, G., Land, J. M., McDonald, W. I., Clark, J. B. and Heales, S. J. (1997) Pretreatment of astrocytes with interferon-alpha/ beta impairs interferon-gamma induction of nitric oxide synthase. J. Neurochem. 68, 2547-2551.
206. Barca, O., Ferre, S., Seoane, M., Prieto, J. M., Lema, M., Senaris, R. and Arce, V. M. (2003) Interferon beta promotes survival in primary astrocytes through phosphatidylinositol 3-kinase. J. Neuroimmunol. 139, 155-159.
207. McLaurin, J., Antel, J. P. and Yong, V. W. (1995) Immune and non-immune actions of interferon-beta-Ib on primary human neural cells. Mult. Scler. 1, 10-19.
208. Neuhaus, O., Stuve, O., Zamvil, S. S. and Hartung, H. P. (2004) Are statins a treatment option for multiple sclerosis? Lancet Neurol. 3, 369-371.
209. Vollmer, T., Key, L., Durkalski, V., Tyor, W., Corboy, J., Markovic-Plese, S., Preiningerova, J., Rizzo, M. and Singh, I. (2004) Oral simvastatin treatment in relapsing-remitting multiple sclerosis. Lancet 363, 1607-1608.
210. Zeinstra, E., Wilczak, N., Chesik, D., Glazenburg, L., Kroese, F. G. and De Keyser, J. (2006) Simvastatin inhibits interferon-gamma-induced MHC class II up-regulation in cultured astrocytes. J Neuroinflammation 3, 16.
211. Satoh, J., Paty, D. W. and Kim, S. U. (1996) Counteracting effect of IFN-beta on IFN-gamma-induced proliferation of human astrocytes in culture. Mult. Scler. 1, 279-287.
212. Youssef, S., Stuve, O., Patarroyo, J. C., Ruiz, P. J., Radosevich, J. L., Hur, E. M., Bravo, M., Mitchell, D. J., Sobel, R. A., Steinman, L. and Zamvil, S. S. (2002) The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease. Nature 420, 78-84.
213. Xu, J. and Drew, P. D. (2006) 9-Cis-retinoic acid suppresses inflammatory responses of microglia and astrocytes. J. Neuroimmunol. 171, 135-144.
214. Xu, J., Chavis, J. A., Racke, M. K. and Drew, P. D. (2006) Peroxisome proliferator-activated receptor-alpha and retinoid X receptor agonists inhibit inflammatory responses of astrocytes. J. Neuroimmunol. 176, 95-105.
215. Lovett-Racke, A. E., Hussain, R. Z., Northrop, S., Choy, J., Rocchini, A., Matthes, L., Chavis, J. A., Diab, A., Drew, P. D. and Racke, M. K. (2004) Peroxisome proliferator-activated receptor alpha agonists as therapy for autoimmune disease. J. Immunol. 172, 5790-5798.
216. Marx, N., Kehrle, B., Kohlhammer, K., Grub, M., Koenig, W., Hombach, V., Libby, P. and Plutzky, J. (2002) PPAR activators as antiinflammatory mediators in human T lymphocytes: implications for atherosclerosis and transplantation-associated arteriosclerosis. Circ. Res. 90, 703-710.